Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 8,826 shares at $17.01 ($150K) on 2025-08-22, disclosed to the SEC on 2025-08-26.
Scheduled sale ($150k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.01 | 4,413 | $75K | 50.0% |
| 2 | $17.01 | 4,413 | $75K | 50.0% |
| Total | $17.01 avg | 8,826 | $150K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |